Amgen’s Sustainability Track Record Includes Reducing Carbon, Water, and Waste
Author: Ken Silverstein
Amgen Inc. is a multinational pharmaceutical company based in Thousand Oaks, Calif. It is one of the world’s largest drug enterprises, and it was established in 1980. It has 24,000 employees and $26 billion in revenues. It operates in 100 countries. Beyond healing people, the company aims to minimize its environmental impact and preserve natural resources for generations. Amgen is a signatory to the U.N. Global Compact. Its goal is carbon neutrality by 2027 - a path it set out on in in 2008. It has been named to Newsweek magazine’s “Most Responsible Companies” for three years and Barron’s “most sustainable” companies for two years straight. “We also announced plans for new manufacturing facilities in North Carolina and Ohio that will utilize cutting-edge technologies to be much more efficient and environmentally friendly than traditional plants,” says Robert Bradway, chief executive officer of Amgen, in the company’s sustainability paper. Its investment in environmental sustainability makes good business sense too. The company is more efficient, productive, and resilient. That has resulted in lower operating costs, it says.